Drug shortage
Bupivacaine Hydrochloride Injection · Kindos Pharmaceuticals Co. Ltd.
FDA drug shortage · Current · updated Mar 11, 2025
Key facts
| Generic name | Bupivacaine Hydrochloride Injection |
|---|---|
| Proprietary name | Bupivacaine Hydrochloride |
| Company | Kindos Pharmaceuticals Co. Ltd. |
| Presentation | Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-722-32) |
| Dosage form | Injection |
| Strength | 2.5 mg/1 mL |
| Status | Current |
| Therapeutic category | Anesthesia |
| Package NDCs | 71288-722-32 |
| First posted | Feb 20, 2018 |
| Last updated | Mar 11, 2025 |
At a glance
- 1–9 Package NDCs affected
- 100–999 FDA shortage records for this drug
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug shortages
The FDA Drug Shortages Database lists current and resolved shortages of drugs, with presentations, affected NDCs and reasons reported by manufacturers.
Source: U.S. Food and Drug Administration (FDA), Drug Shortages Database · Source date: